Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Morphogenetic Proteins | 7 | 2010 | 24 | 1.870 |
Why?
|
Transforming Growth Factor beta | 6 | 2010 | 66 | 1.480 |
Why?
|
Osteogenesis, Distraction | 5 | 2010 | 19 | 1.310 |
Why?
|
Cleft Lip | 6 | 2009 | 12 | 1.300 |
Why?
|
Cleft Palate | 6 | 2009 | 18 | 1.290 |
Why?
|
Adipose Tissue | 2 | 2017 | 327 | 0.970 |
Why?
|
Collagen | 5 | 2009 | 217 | 0.900 |
Why?
|
Craniofacial Abnormalities | 3 | 2008 | 12 | 0.850 |
Why?
|
Mandible | 5 | 2008 | 38 | 0.810 |
Why?
|
Surgical Flaps | 4 | 2017 | 69 | 0.800 |
Why?
|
Reconstructive Surgical Procedures | 6 | 2017 | 190 | 0.790 |
Why?
|
Face | 3 | 2008 | 25 | 0.790 |
Why?
|
Osteogenesis | 4 | 2009 | 75 | 0.750 |
Why?
|
Alveolar Process | 3 | 2009 | 5 | 0.700 |
Why?
|
Bone Regeneration | 3 | 2008 | 28 | 0.670 |
Why?
|
Gelatin Sponge, Absorbable | 3 | 2005 | 5 | 0.620 |
Why?
|
Skin Transplantation | 2 | 2017 | 50 | 0.620 |
Why?
|
Hand Injuries | 1 | 2017 | 24 | 0.610 |
Why?
|
Biocompatible Materials | 4 | 2006 | 210 | 0.600 |
Why?
|
Peripheral Vascular Diseases | 1 | 2016 | 35 | 0.580 |
Why?
|
Stromal Cells | 1 | 2016 | 70 | 0.570 |
Why?
|
Recombinant Proteins | 5 | 2010 | 248 | 0.570 |
Why?
|
Neck | 2 | 2008 | 26 | 0.550 |
Why?
|
Lower Extremity | 1 | 2016 | 93 | 0.550 |
Why?
|
Head | 2 | 2008 | 47 | 0.540 |
Why?
|
Bone Morphogenetic Protein 2 | 6 | 2010 | 21 | 0.450 |
Why?
|
Mandibular Advancement | 1 | 2010 | 2 | 0.380 |
Why?
|
Pierre Robin Syndrome | 1 | 2010 | 9 | 0.380 |
Why?
|
Airway Obstruction | 1 | 2010 | 31 | 0.380 |
Why?
|
Mesoderm | 2 | 2008 | 14 | 0.370 |
Why?
|
Absorbable Implants | 1 | 2009 | 24 | 0.350 |
Why?
|
Follow-Up Studies | 5 | 2017 | 2108 | 0.350 |
Why?
|
Micrognathism | 1 | 2008 | 2 | 0.330 |
Why?
|
Branchial Region | 1 | 2008 | 4 | 0.320 |
Why?
|
Neural Crest | 2 | 2004 | 3 | 0.300 |
Why?
|
Fibroma, Ossifying | 1 | 2006 | 2 | 0.290 |
Why?
|
Mandibular Neoplasms | 1 | 2006 | 6 | 0.290 |
Why?
|
Mandibular Diseases | 1 | 2005 | 2 | 0.280 |
Why?
|
Alveoloplasty | 1 | 2005 | 3 | 0.270 |
Why?
|
Organizers, Embryonic | 2 | 2004 | 2 | 0.270 |
Why?
|
Humans | 15 | 2017 | 29093 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 337 | 0.230 |
Why?
|
Stem Cells | 1 | 2006 | 292 | 0.230 |
Why?
|
Child, Preschool | 5 | 2008 | 1167 | 0.230 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 9 | 0.210 |
Why?
|
Body Patterning | 1 | 2002 | 5 | 0.210 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2017 | 75 | 0.210 |
Why?
|
Infant, Newborn | 4 | 2010 | 598 | 0.200 |
Why?
|
Wound Healing | 2 | 2016 | 182 | 0.190 |
Why?
|
Mesenchymal Stem Cells | 2 | 2017 | 161 | 0.190 |
Why?
|
Male | 6 | 2017 | 17807 | 0.170 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 64 | 0.150 |
Why?
|
Treatment Outcome | 4 | 2010 | 3099 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 103 | 0.150 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 78 | 0.150 |
Why?
|
Ischemia | 1 | 2017 | 92 | 0.150 |
Why?
|
Ankle Brachial Index | 1 | 2016 | 37 | 0.150 |
Why?
|
Arteriosclerosis | 1 | 2016 | 116 | 0.140 |
Why?
|
Angiography | 1 | 2016 | 75 | 0.140 |
Why?
|
Child | 4 | 2008 | 2219 | 0.140 |
Why?
|
Periosteum | 2 | 2006 | 9 | 0.140 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 106 | 0.140 |
Why?
|
Female | 6 | 2016 | 18164 | 0.140 |
Why?
|
Cells, Cultured | 1 | 2016 | 799 | 0.130 |
Why?
|
Retrospective Studies | 3 | 2010 | 3111 | 0.110 |
Why?
|
Infant | 3 | 2005 | 969 | 0.110 |
Why?
|
Animals | 4 | 2008 | 7297 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 1218 | 0.100 |
Why?
|
Tomography, Spiral Computed | 1 | 2009 | 18 | 0.090 |
Why?
|
Intubation, Intratracheal | 1 | 2010 | 70 | 0.090 |
Why?
|
Aged, 80 and over | 1 | 2016 | 3717 | 0.080 |
Why?
|
Oral Surgical Procedures | 1 | 2008 | 7 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 1379 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2008 | 50 | 0.080 |
Why?
|
Reoperation | 1 | 2008 | 203 | 0.080 |
Why?
|
Calcium Phosphates | 1 | 2006 | 9 | 0.070 |
Why?
|
Bone Substitutes | 1 | 2006 | 8 | 0.070 |
Why?
|
Durapatite | 1 | 2006 | 8 | 0.070 |
Why?
|
Masseter Muscle | 1 | 2005 | 1 | 0.070 |
Why?
|
Temporal Muscle | 1 | 2005 | 1 | 0.070 |
Why?
|
Osteocytes | 1 | 2005 | 4 | 0.070 |
Why?
|
Bone Remodeling | 1 | 2005 | 8 | 0.070 |
Why?
|
Adult | 2 | 2017 | 8420 | 0.070 |
Why?
|
Tooth Eruption | 1 | 2005 | 2 | 0.070 |
Why?
|
Drug Carriers | 1 | 2005 | 16 | 0.070 |
Why?
|
Bone Plates | 1 | 2006 | 68 | 0.070 |
Why?
|
Osteoblasts | 1 | 2005 | 46 | 0.070 |
Why?
|
Postoperative Complications | 1 | 2010 | 670 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2005 | 95 | 0.070 |
Why?
|
Suture Techniques | 1 | 2005 | 56 | 0.070 |
Why?
|
Swine | 1 | 2005 | 201 | 0.070 |
Why?
|
Aged | 2 | 2016 | 9487 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2005 | 263 | 0.060 |
Why?
|
Bone Density | 1 | 2006 | 182 | 0.060 |
Why?
|
Contracture | 1 | 2004 | 14 | 0.060 |
Why?
|
Skin, Artificial | 1 | 2004 | 31 | 0.060 |
Why?
|
Nose | 1 | 2004 | 12 | 0.060 |
Why?
|
Middle Aged | 2 | 2016 | 10829 | 0.060 |
Why?
|
Mouth | 1 | 2004 | 22 | 0.060 |
Why?
|
Cicatrix | 1 | 2004 | 36 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2005 | 436 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2005 | 573 | 0.060 |
Why?
|
Time Factors | 2 | 2004 | 2001 | 0.050 |
Why?
|
Olfactory Pathways | 1 | 2002 | 16 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2005 | 980 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2002 | 62 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2002 | 68 | 0.050 |
Why?
|
Carotid Arteries | 1 | 2002 | 97 | 0.050 |
Why?
|
Fetus | 1 | 2002 | 78 | 0.050 |
Why?
|
Pregnancy | 1 | 2004 | 815 | 0.050 |
Why?
|
Adolescent | 2 | 2005 | 3254 | 0.050 |
Why?
|
Chondroitin Sulfates | 1 | 2004 | 22 | 0.020 |
Why?
|